IBDEI2XH ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46728,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46728,1,3,0)
;;=3^Hydronephrosis w/ Ureteral Stricture NEC
;;^UTILITY(U,$J,358.3,46728,1,4,0)
;;=4^N13.1
;;^UTILITY(U,$J,358.3,46728,2)
;;=^5015576
;;^UTILITY(U,$J,358.3,46729,0)
;;=N13.2^^179^2329^7
;;^UTILITY(U,$J,358.3,46729,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46729,1,3,0)
;;=3^Hydronephrosis w/ Renal & Ureteral Calculous Obstruction
;;^UTILITY(U,$J,358.3,46729,1,4,0)
;;=4^N13.2
;;^UTILITY(U,$J,358.3,46729,2)
;;=^5015577
;;^UTILITY(U,$J,358.3,46730,0)
;;=N13.30^^179^2329^11
;;^UTILITY(U,$J,358.3,46730,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46730,1,3,0)
;;=3^Hydronephrosis,Unspec
;;^UTILITY(U,$J,358.3,46730,1,4,0)
;;=4^N13.30
;;^UTILITY(U,$J,358.3,46730,2)
;;=^5015578
;;^UTILITY(U,$J,358.3,46731,0)
;;=N13.39^^179^2329^10
;;^UTILITY(U,$J,358.3,46731,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46731,1,3,0)
;;=3^Hydronephrosis,Other
;;^UTILITY(U,$J,358.3,46731,1,4,0)
;;=4^N13.39
;;^UTILITY(U,$J,358.3,46731,2)
;;=^5015579
;;^UTILITY(U,$J,358.3,46732,0)
;;=N13.4^^179^2329^12
;;^UTILITY(U,$J,358.3,46732,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46732,1,3,0)
;;=3^Hydroureter
;;^UTILITY(U,$J,358.3,46732,1,4,0)
;;=4^N13.4
;;^UTILITY(U,$J,358.3,46732,2)
;;=^186913
;;^UTILITY(U,$J,358.3,46733,0)
;;=N13.5^^179^2329^6
;;^UTILITY(U,$J,358.3,46733,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46733,1,3,0)
;;=3^Crossing Vessel & Stricture of Ureter w/o Hydronephrosis
;;^UTILITY(U,$J,358.3,46733,1,4,0)
;;=4^N13.5
;;^UTILITY(U,$J,358.3,46733,2)
;;=^5015580
;;^UTILITY(U,$J,358.3,46734,0)
;;=N13.6^^179^2329^29
;;^UTILITY(U,$J,358.3,46734,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46734,1,3,0)
;;=3^Pyonephrosis
;;^UTILITY(U,$J,358.3,46734,1,4,0)
;;=4^N13.6
;;^UTILITY(U,$J,358.3,46734,2)
;;=^101552
;;^UTILITY(U,$J,358.3,46735,0)
;;=N16.^^179^2329^31
;;^UTILITY(U,$J,358.3,46735,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46735,1,3,0)
;;=3^Renal Tubulo-Interstitial D/O in Diseases Classd Elswhr
;;^UTILITY(U,$J,358.3,46735,1,4,0)
;;=4^N16.
;;^UTILITY(U,$J,358.3,46735,2)
;;=^5015597
;;^UTILITY(U,$J,358.3,46736,0)
;;=N17.0^^179^2329^19
;;^UTILITY(U,$J,358.3,46736,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46736,1,3,0)
;;=3^Kidney Failure,Acute w/ Tubular Necrosis
;;^UTILITY(U,$J,358.3,46736,1,4,0)
;;=4^N17.0
;;^UTILITY(U,$J,358.3,46736,2)
;;=^5015598
;;^UTILITY(U,$J,358.3,46737,0)
;;=N17.1^^179^2329^17
;;^UTILITY(U,$J,358.3,46737,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46737,1,3,0)
;;=3^Kidney Failure,Acute w/ Acute Cortical Necrosis
;;^UTILITY(U,$J,358.3,46737,1,4,0)
;;=4^N17.1
;;^UTILITY(U,$J,358.3,46737,2)
;;=^5015599
;;^UTILITY(U,$J,358.3,46738,0)
;;=N17.2^^179^2329^18
;;^UTILITY(U,$J,358.3,46738,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46738,1,3,0)
;;=3^Kidney Failure,Acute w/ Medullary Necrosis
;;^UTILITY(U,$J,358.3,46738,1,4,0)
;;=4^N17.2
;;^UTILITY(U,$J,358.3,46738,2)
;;=^5015600
;;^UTILITY(U,$J,358.3,46739,0)
;;=N17.8^^179^2329^21
;;^UTILITY(U,$J,358.3,46739,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46739,1,3,0)
;;=3^Kidney Failure,Other Acute
;;^UTILITY(U,$J,358.3,46739,1,4,0)
;;=4^N17.8
;;^UTILITY(U,$J,358.3,46739,2)
;;=^5015601
;;^UTILITY(U,$J,358.3,46740,0)
;;=N17.9^^179^2329^20
;;^UTILITY(U,$J,358.3,46740,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2XH 3770 printed Nov 22, 2024@17:47:53 Page 2
IBDEI2XH ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46728,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,46728,1,3,0)
+4 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
+5 ;;^UTILITY(U,$J,358.3,46728,1,4,0)
+6 ;;=4^N13.1
+7 ;;^UTILITY(U,$J,358.3,46728,2)
+8 ;;=^5015576
+9 ;;^UTILITY(U,$J,358.3,46729,0)
+10 ;;=N13.2^^179^2329^7
+11 ;;^UTILITY(U,$J,358.3,46729,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,46729,1,3,0)
+14 ;;=3^Hydronephrosis w/ Renal & Ureteral Calculous Obstruction
+15 ;;^UTILITY(U,$J,358.3,46729,1,4,0)
+16 ;;=4^N13.2
+17 ;;^UTILITY(U,$J,358.3,46729,2)
+18 ;;=^5015577
+19 ;;^UTILITY(U,$J,358.3,46730,0)
+20 ;;=N13.30^^179^2329^11
+21 ;;^UTILITY(U,$J,358.3,46730,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,46730,1,3,0)
+24 ;;=3^Hydronephrosis,Unspec
+25 ;;^UTILITY(U,$J,358.3,46730,1,4,0)
+26 ;;=4^N13.30
+27 ;;^UTILITY(U,$J,358.3,46730,2)
+28 ;;=^5015578
+29 ;;^UTILITY(U,$J,358.3,46731,0)
+30 ;;=N13.39^^179^2329^10
+31 ;;^UTILITY(U,$J,358.3,46731,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,46731,1,3,0)
+34 ;;=3^Hydronephrosis,Other
+35 ;;^UTILITY(U,$J,358.3,46731,1,4,0)
+36 ;;=4^N13.39
+37 ;;^UTILITY(U,$J,358.3,46731,2)
+38 ;;=^5015579
+39 ;;^UTILITY(U,$J,358.3,46732,0)
+40 ;;=N13.4^^179^2329^12
+41 ;;^UTILITY(U,$J,358.3,46732,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,46732,1,3,0)
+44 ;;=3^Hydroureter
+45 ;;^UTILITY(U,$J,358.3,46732,1,4,0)
+46 ;;=4^N13.4
+47 ;;^UTILITY(U,$J,358.3,46732,2)
+48 ;;=^186913
+49 ;;^UTILITY(U,$J,358.3,46733,0)
+50 ;;=N13.5^^179^2329^6
+51 ;;^UTILITY(U,$J,358.3,46733,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,46733,1,3,0)
+54 ;;=3^Crossing Vessel & Stricture of Ureter w/o Hydronephrosis
+55 ;;^UTILITY(U,$J,358.3,46733,1,4,0)
+56 ;;=4^N13.5
+57 ;;^UTILITY(U,$J,358.3,46733,2)
+58 ;;=^5015580
+59 ;;^UTILITY(U,$J,358.3,46734,0)
+60 ;;=N13.6^^179^2329^29
+61 ;;^UTILITY(U,$J,358.3,46734,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,46734,1,3,0)
+64 ;;=3^Pyonephrosis
+65 ;;^UTILITY(U,$J,358.3,46734,1,4,0)
+66 ;;=4^N13.6
+67 ;;^UTILITY(U,$J,358.3,46734,2)
+68 ;;=^101552
+69 ;;^UTILITY(U,$J,358.3,46735,0)
+70 ;;=N16.^^179^2329^31
+71 ;;^UTILITY(U,$J,358.3,46735,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,46735,1,3,0)
+74 ;;=3^Renal Tubulo-Interstitial D/O in Diseases Classd Elswhr
+75 ;;^UTILITY(U,$J,358.3,46735,1,4,0)
+76 ;;=4^N16.
+77 ;;^UTILITY(U,$J,358.3,46735,2)
+78 ;;=^5015597
+79 ;;^UTILITY(U,$J,358.3,46736,0)
+80 ;;=N17.0^^179^2329^19
+81 ;;^UTILITY(U,$J,358.3,46736,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,46736,1,3,0)
+84 ;;=3^Kidney Failure,Acute w/ Tubular Necrosis
+85 ;;^UTILITY(U,$J,358.3,46736,1,4,0)
+86 ;;=4^N17.0
+87 ;;^UTILITY(U,$J,358.3,46736,2)
+88 ;;=^5015598
+89 ;;^UTILITY(U,$J,358.3,46737,0)
+90 ;;=N17.1^^179^2329^17
+91 ;;^UTILITY(U,$J,358.3,46737,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,46737,1,3,0)
+94 ;;=3^Kidney Failure,Acute w/ Acute Cortical Necrosis
+95 ;;^UTILITY(U,$J,358.3,46737,1,4,0)
+96 ;;=4^N17.1
+97 ;;^UTILITY(U,$J,358.3,46737,2)
+98 ;;=^5015599
+99 ;;^UTILITY(U,$J,358.3,46738,0)
+100 ;;=N17.2^^179^2329^18
+101 ;;^UTILITY(U,$J,358.3,46738,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,46738,1,3,0)
+104 ;;=3^Kidney Failure,Acute w/ Medullary Necrosis
+105 ;;^UTILITY(U,$J,358.3,46738,1,4,0)
+106 ;;=4^N17.2
+107 ;;^UTILITY(U,$J,358.3,46738,2)
+108 ;;=^5015600
+109 ;;^UTILITY(U,$J,358.3,46739,0)
+110 ;;=N17.8^^179^2329^21
+111 ;;^UTILITY(U,$J,358.3,46739,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,46739,1,3,0)
+114 ;;=3^Kidney Failure,Other Acute
+115 ;;^UTILITY(U,$J,358.3,46739,1,4,0)
+116 ;;=4^N17.8
+117 ;;^UTILITY(U,$J,358.3,46739,2)
+118 ;;=^5015601
+119 ;;^UTILITY(U,$J,358.3,46740,0)
+120 ;;=N17.9^^179^2329^20
+121 ;;^UTILITY(U,$J,358.3,46740,1,0)
+122 ;;=^358.31IA^4^2
